OpenEvidence's AI medical search tool hits $15 billion valuation
OpenEvidence, a Miami-based AI search startup founded by Daniel Nadler in 2022, says nearly two-thirds of US physicians now use its chatbot to consult medical journals and clinical guidelines, with over 42 million prompts processed last month. The company raised $250 million in September at a $15 billion valuation, backed by investors including Andreessen Horowitz, Blackstone, Thrive Capital and Sequoia, and reported $100 million in ad commitments for 2025.